Results 11 to 20 of about 213,305 (310)
Effectiveness of reactive hepatitis therapy in injured with ballistic wounds
Ukrainian Scientific Medical Youth Journal, 2022 Reactive hepatitis complicates the treatment of ballistic wounds. The aim of our study was to study the clinical and pharmacoeconomic effectiveness of the treatment of reactive hepatitis in the wounded.
Kyrylo Savichan
doaj +1 more source
Contractual procurement alternatives of air force contingency pharmaceuticals: a cost-benefit analysis [PDF]
Journal of Defense Analytics and Logistics, 2020 Purpose – This paper aims to explore effective supply chain principles, through the theory of transaction cost economics, as measures to improve current contingency pharmaceutical item shortfalls in the Air Force Medical Service (AFMS) Contingency ...
Adam J. Brubakken +3 more
doaj +1 more source
What, who and when? Incorporating a discrete choice experiment into an economic evaluation [PDF]
, 2016 Acknowledgements The Medman study was funded by the Department of Health for England and Wales and managed by a collaboration of the National Pharmaceutical Association, the Royal Pharmaceutical Society of Great Britain, the Company Chemist Association ...
Bond, Christine +2 more
core +2 more sources
Biomédica: revista del Instituto Nacional de Salud, 2010 Introducción. En países de ingresos altos, el tamoxifeno ha venido siendo reemplazado por los inhibidores de la aromatasa –como el anastrazol– en la terapia hormonal adyuvante en el cáncer temprano de mama con receptor hormonal positivo, por sus mejores ...
Óscar Gamboa +3 more
doaj +1 more source
Brazilian Journal of Nephrology, 2021 Introduction: The number of kidney transplants (KTx) is increasing in Brazil and, consequently, the costs of this procedure increase the country's health budget.
Raquel Martins e Quinino +4 more
doaj +2 more sources
Can’t Buy Me Rights! The Contractual Structure of Asymmetrical Inter-firm Collaborations [PDF]
, 2006 The efficient allocation of control rights in inter-firm collaborations is a widely emphasized issue. In this paper, I empirically identify control rights and the allocation of these rights using a unique survey data set on collaborations between ...
Häussler, Carolin
core +2 more sources
High growth firms, innovation and competition: the case of the US pharmaceutical industry [PDF]
, 2013 Innovation is key to economic growth. But firms, across sectors and regions, are highly skewed in their ability to engage with innovation, and even more skewed in their ability to translate investments in innovation into higher growth.
Mazzucato, Mariana, Parris, Stuart
core +2 more sources
Cost-benefit analysis of pharmacist interventions over 36 months in a university hospital
Revista de Saúde Pública, 2020 OBJECTIVE: To perform a cost-benefits analysis of a clinical pharmacy (CP) service implemented in a Neurology ward of a tertiary teaching hospital. METHODS: This is a cost-benefit analysis of a single arm, prospective cohort study performed at the adult
Maurilio de Souza Cazarim +4 more
doaj +1 more source
Development of Holistic integrative pharmacy Based on Clinical Pharmacy
Journal of Holistic Integrative Pharmacy, 2020 [Abstract]: With advances in modern medicine, life science technologies, economics, information technologies, and the Internet, the focus of clinical pharmacy is transitioning from drug product-oriented to patient-oriented.
Xin ZHAO, Xiong LI
doaj +1 more source
Valuation implications of pharmaceutical companies' R&D regulatory approval notifications [PDF]
, 2013 This paper examines shareholder wealth effects surrounding applications to, and approvals by, the United States Food and Drug Administration (FDA) for firms listed on the New York (NYSE) and London (LSE) stock exchanges.
Hamill, P.A., McIlkenny, P., Opong, K.K.
core +1 more source